Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effectsK Ahmad, Ahmet Cumaoğlu|Naunyn-Schmiedeberg s Archives of Pharmacology|2024Cited by 11